Artivion Inc (AORT)
Healthcare
Medical Devices
26.80 $
-3.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Artivion Inc (AORT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.7% of the shares are freely tradable; institutional investors hold 93.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
93.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
4.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
94.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
4.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
49Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 13.34 | 6,474,854 | +1.7 | 03/31/2026 |
| Vanguard Group Inc | 6.53 | 3,170,089 | +4.7 | 12/31/2025 |
| FMR Inc | 5.32 | 2,583,427 | +1.6 | 03/31/2026 |
| Delaware Management Holdings Inc | 5.06 | 2,456,146 | -6.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 4.67 | 2,269,294 | +0.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.02 | 1,952,008 | +0.0 | 03/31/2026 |
| State Street Corp | 3.47 | 1,682,273 | +6.1 | 03/31/2026 |
| Perceptive Advisors LLC | 3.37 | 1,637,290 | -4.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.28 | 2,563,135 | +0.0 | 05/29/2026 |
| Nomura US Small Cap Core Equity | 3.07 | 1,487,922 | +3.7 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.